For the Inventor, By the Inventor

Enter assignee name

Nucryst Pharmaceuticals Corp.

USPTO Granted Patents = 15

CIPO Patents = 1

Trademarks = 1

Forward Citations = 585

Loading Chart...

Loading Chart...

18 inventors (with patents filed for the assignee):

Robert Edward Burrell (11 out of 30 patents)

Paul Schechter (6 out of 6 patents)

Scott H Gillis (6 out of 7 patents)

4. Hua Qing Yin (6 out of 6 patents)

5. Antony George Naylor (4 out of 4 patents)

6. Peter Howard Moxham (4 out of 4 patents)

7. Kan Lam (3 out of 4 patents)

8. John Barrymore Wright (3 out of 4 patents)

9. James Alexander Robert Stiles (2 out of 12 patents)

10. Katherine Jane Turner (1 out of 14 patents)

11. Jeffrey B Lyczak (1 out of 1 patent)

12. Katherine Thompson (1 out of 1 patent)

13. Stojan Djokic (1 out of 6 patents)

14. Walter Carlton Theodore Cholowski (1 out of 1 patent)

15. Leonard Salvin Bowlby (1 out of 1 patent)

15 patents: Sort by Forward Citations

1. 8425880 - Metal-containing materials for treatment of bacterial conditions (2013-04-23),

2. 7470437 - Methods of treating conditions with a metal-containing material (2008-12-30),

3. 7427416 - Methods of treating conditions using metal-containing materials (2008-09-23),

4. 7255881 - Metal-containing materials (2007-08-14),

5. 7137968 - Transcutaneous medical device dressings and method of use (2006-11-21),

6. 7087249 - Treatment of mucosal membranes (2006-08-08),

7. 7078060 - Solutions and aerosols of metal-containing compounds (2006-07-18),

8. 7008647 - Treatment of acne (2006-03-07),

9. 6989157 - Dry powders of metal-containing compounds (2006-01-24),

10. 6989156 - Therapeutic treatments using the direct application of antimicrobial metal compositions (2006-01-24),

11. 6939568 - Treatment of inflammatory skin conditions (2005-09-06),

12. 6723350 - Lubricious coatings for substrates (2004-04-20),

13. 6719987 - Antimicrobial bioabsorbable materials (2004-04-13),

14. 6692773 - Treatment of hyperproliferative skin disorders and diseases (2004-02-17),

15. 6365220 - Process for production of actively sterile surfaces (2002-04-02),

Nucryst Pharmaceuticals Corp. is a pharmaceutical company specializing in developing and commercializing innovative products based on proprietary nanocrystalline silver technology. With a focus on advanced wound care, the company creates medical solutions for the prevention and treatment of infections. Nucryst Pharmaceuticals Corp. is dedicated to improving patient outcomes and quality of life through the use of safe and effective antimicrobial technologies.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

15 Patents

#3 in Fort

#945 in Canada

#38,730 in the World

Nucryst Pharmaceuticals Corp.

Forward Citations = 585

18 inventors:

Robert Edward Burrell (11 out of 30 patents)

Paul Schechter (6 out of 6 patents)

Scott H Gillis (6 out of 7 patents)

4. Hua Qing Yin (6 out of 6 patents)

5. Antony George Naylor (4 out of 4 patents)

Please report any incorrect information to support@idiyas.com

Loading…